Compass Therapeutics Inc. (CMPX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $139.35M
Last updated: Nov 17, 2026 at 11:04 AM ET
Compass Therapeutics Inc. (CMPX) Earnings: Report Dates and Results
Compass Therapeutics (CMPX) is expected to report earnings on Mar 3, 2027. In the quarter ended Sep 30, 2026, Compass Therapeutics reported EPS of -$0.15, below the -$0.12 estimate. It beat the EPS estimate in 2 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
CMPX has an expected report date of Mar 3, 2027.
Earnings History
Of the 22 quarters below that had an estimate, CMPX beat 9, missed 11 and matched 2. The widest gap in the table came in the quarter ended Dec 31, 2021, when EPS landed 200.00% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.15 | -$0.12 | -$0.15 - -$0.10 | -25.00% | Miss | N/A | 11 | 2 up, 0 down | Nov 9, 2026 |
| Jun 30, 2026 | -$0.13 | -$0.10 | -$0.15 - -$0.09 | -30.00% | Miss | N/A | 12 | 0 up, 3 down | Aug 6, 2026 |
| Mar 31, 2026 | -$0.10 | -$0.10 | -$0.15 - -$0.06 | 0.00% | In line | N/A | 11 | 1 up, 4 down | May 5, 2026 |
| Dec 31, 2025 | -$0.09 | -$0.10 | -$0.14 - -$0.02 | +5.66% | Beat | N/A | 13 | 6 up, 1 down | Mar 5, 2026 |
| Sep 30, 2025 | -$0.08 | -$0.14 | -$0.17 - -$0.09 | +42.86% | Beat | N/A | 8 | N/A | Nov 5, 2025 |
| Jun 30, 2025 | -$0.14 | -$0.12 | -$0.13 - -$0.09 | -16.67% | Miss | N/A | 7 | 1 up, 0 down | Aug 11, 2025 |
| Mar 31, 2025 | -$0.12 | -$0.11 | -$0.15 - -$0.05 | -9.09% | Miss | N/A | 9 | 0 up, 2 down | May 8, 2025 |
| Dec 31, 2024 | -$0.11 | -$0.10 | -$0.14 - -$0.06 | -10.00% | Miss | N/A | 9 | 1 up, 0 down | Feb 27, 2025 |
| Sep 30, 2024 | -$0.08 | -$0.11 | -$0.14 - -$0.10 | +27.27% | Beat | N/A | 6 | 0 up, 0 down | Nov 12, 2024 |
| Jun 30, 2024 | -$0.10 | -$0.09 | -$0.11 - -$0.08 | -11.11% | Miss | N/A | 6 | 0 up, 0 down | Aug 12, 2024 |
| Mar 31, 2024 | -$0.08 | -$0.11 | -$0.12 - -$0.10 | +27.27% | Beat | N/A | 7 | 0 up, 0 down | May 13, 2024 |
| Dec 31, 2023 | -$0.11 | -$0.09 | -$0.11 - -$0.08 | -22.22% | Miss | N/A | 7 | 0 up, 0 down | Mar 21, 2024 |
| Sep 30, 2023 | -$0.08 | -$0.11 | -$0.12 - -$0.09 | +27.27% | Beat | N/A | 7 | 0 up, 0 down | Nov 9, 2023 |
| Jun 30, 2023 | -$0.09 | -$0.08 | -$0.10 - -$0.07 | -12.50% | Miss | N/A | 7 | 0 up, 0 down | Aug 3, 2023 |
| Mar 31, 2023 | -$0.06 | -$0.11 | -$0.12 - -$0.10 | +45.45% | Beat | N/A | 7 | 0 up, 0 down | May 4, 2023 |
| Dec 31, 2022 | -$0.10 | -$0.11 | -$0.13 - -$0.10 | +9.09% | Beat | N/A | 8 | 0 up, 0 down | Mar 15, 2023 |
| Sep 30, 2022 | -$0.12 | -$0.12 | -$0.16 - -$0.09 | 0.00% | In line | N/A | 6 | 0 up, 0 down | Nov 9, 2022 |
| Jun 30, 2022 | -$0.08 | -$0.07 | -$0.14 - -$0.06 | -14.29% | Miss | N/A | 7 | 0 up, 0 down | Aug 1, 2022 |
| Mar 31, 2022 | -$0.07 | -$0.13 | -$0.15 - -$0.07 | +46.15% | Beat | N/A | 6 | 0 up, 0 down | May 9, 2022 |
| Dec 31, 2021 | -$0.21 | -$0.07 | -$0.08 - -$0.07 | -200.00% | Miss | N/A | 7 | 0 up, 0 down | Mar 21, 2022 |
| Sep 30, 2021 | -$0.10 | -$0.11 | -$0.15 - -$0.10 | +9.09% | Beat | N/A | 2 | N/A | Nov 12, 2021 |
| Jun 30, 2021 | -$1.07 | -$1.03 | N/A | -3.88% | Miss | N/A | N/A | N/A | Aug 16, 2021 |
| Mar 31, 2021 | -$0.14 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 30, 2021 |
| Dec 31, 2020 | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 5, 2021 |
| Sep 30, 2020 | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 9, 2020 |
| Jun 30, 2020 | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 13, 2020 |
| Mar 31, 2020 | -$0.41 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 8, 2020 |
| Dec 31, 2019 | -$0.90 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 13, 2020 |
| Sep 30, 2019 | -$0.95 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 13, 2019 |
| Jun 30, 2019 | -$1.27 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 1, 2019 |
| Mar 31, 2019 | -$1.33 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 30, 2019 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.43, after -$0.37 the year before. It was -$4.45 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.43 | N/A |
| Dec 31, 2024 | -$0.37 | N/A |
| Dec 31, 2023 | -$0.34 | N/A |
| Dec 31, 2022 | -$0.37 | N/A |
| Dec 31, 2021 | -$1.52 | N/A |
| Dec 31, 2020 | -$0.93 | N/A |
| Dec 31, 2019 | -$4.45 | N/A |
Frequently Asked Questions About CMPX
When is Compass Therapeutics's next earnings date?
Compass Therapeutics's next earnings report is expected for Mar 3, 2027.
Did CMPX beat earnings estimates last quarter?
No. Compass Therapeutics reported EPS of -$0.15 for the quarter ended Sep 30, 2026, below the -$0.12 estimate by 25.00%.
What EPS do analysts expect from CMPX next quarter?
The consensus EPS estimate for Compass Therapeutics for the quarter ending Dec 31, 2026 is -$0.15 from 17 analysts, with estimates from -$0.17 to -$0.13.
How often does CMPX beat earnings estimates?
Compass Therapeutics beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -5.28%.
CMPX pages: Overview, Earnings, Forecast, Financials, Competitors